小儿先天性心脏病的脑血流监测新进展（New progress in brain blood flow monitoring of congenital heart disease in children）.docVIP

小儿先天性心脏病的脑血流监测新进展（New progress in brain blood flow monitoring of congenital heart disease in children） New progress in brain blood flow monitoring of congenital heart disease in children Children with congenital heart disease (FCHD) due to the change of blood rheology and blood dynamics, significantly affect the central nervous system function, can cause varying degrees of neurological signs and symptoms, affect prognosis, this is mainly because most children with congenital heart disease caused by cerebral blood flow decreased. Application of transcranial doppler ultrasound to monitor cerebral blood flow changes, not only can guide blue FCHT preoperative medical conservative treatment, can also be used for each model a dynamic monitoring of the cerebral blood flow in the treatment of congenital heart disease surgery and cardiac catheterization and emboli monitoring, so as to timely intervention, to improve the prognosis. Transcranial doppler ultrasound technology has been developed in many fields of clinical application, such as non-invasive, convenient, dynamic and unnecessary radiation. [keywords] heart defect, congenital; Ultrasound, doppler, transcranial In recent years, the circulatory monitoring of the perioperative period of congenital heart disease (congenital heart disease) has received more and more attention. Due to pathological changes and surgical treatment of congenital heart disease itself especially hemodynamic changes during extracorporeal circulation, significantly influence the function of the central nervous system (CNS), can cause the corresponding symptoms, even with different degrees of CNS sequelae. Therefore, it is hoped that through transcranial doppler ultrasonography (TCD) technology to monitor cerebral blood flow changes in a timely manner, it will reduce the complications of CNS and improve the prognosis. This article reviews the application of this technique in the field of pediatric congenital heart disease. 1. Development of TCD tec